23andMe Stock: Continued Drug-Development Progress Can Deliver Long-Term Gains
23andMe Stock: Continued Drug-Development Progress Can Deliver Long-Term Gains
Read moreTag: 23andMe
23andMe going public with help of Richard Branson-backed SPAC
A blank-check firm backed by Virgin Group founder Sir Richard Branson is taking consumer DNA-testing firm 23andMe public in a deal that ...
Read more
New 23andMe tool can help you calculate what your risk is of being hospitalized due to COVID-19
A new tool from home genetic testing company 23andMe may be able to predict a person's risk of contracting a ...
Read more
